ESMO MAP 2022 | Increasing the recruitment of high endothelial venules (HEVs) into the tumor
Jean-Philippe Girard
• 13 Oct 2022
Jean-Philippe Girard, PhD, CNRS-Université de Toulouse III, Toulouse, France, discusses the development of methods to increase the recruitment of high endothelial venules (HEVs) to the tumor site to improve the efficacy of immunotherapy. This interview took place at the Molecular Analysis for Precision oncology (MAP) Congress 2022 in Amsterdam, Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
